NO991560L - PDE IV-inhiberende 2-cyanoiminoimidazol-derivater - Google Patents
PDE IV-inhiberende 2-cyanoiminoimidazol-derivaterInfo
- Publication number
- NO991560L NO991560L NO991560A NO991560A NO991560L NO 991560 L NO991560 L NO 991560L NO 991560 A NO991560 A NO 991560A NO 991560 A NO991560 A NO 991560A NO 991560 L NO991560 L NO 991560L
- Authority
- NO
- Norway
- Prior art keywords
- pde
- inhibiting
- cyanoiminoimidazole
- derivatives
- cyanoiminoimidazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96202749 | 1996-10-02 | ||
PCT/EP1997/005322 WO1998014432A1 (en) | 1996-10-02 | 1997-09-24 | Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NO991560D0 NO991560D0 (no) | 1999-03-30 |
NO991560L true NO991560L (no) | 1999-06-02 |
NO312960B1 NO312960B1 (no) | 2002-07-22 |
Family
ID=8224456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19991560A NO312960B1 (no) | 1996-10-02 | 1999-03-30 | PDE IV-inhiberende 2-cyanoiminoimidazol-derivater |
Country Status (31)
Country | Link |
---|---|
US (1) | US6051718A (no) |
EP (1) | EP0934280B1 (no) |
JP (1) | JP3068208B2 (no) |
KR (1) | KR100520002B1 (no) |
CN (1) | CN1106387C (no) |
AR (1) | AR008875A1 (no) |
AT (1) | ATE236884T1 (no) |
AU (1) | AU719561B2 (no) |
BG (1) | BG64278B1 (no) |
BR (1) | BR9712256B1 (no) |
CA (1) | CA2267322C (no) |
CY (1) | CY2380B1 (no) |
CZ (1) | CZ297474B6 (no) |
DE (1) | DE69720757T2 (no) |
DK (1) | DK0934280T3 (no) |
EE (1) | EE03825B1 (no) |
ES (1) | ES2196308T3 (no) |
HK (1) | HK1020344A1 (no) |
HU (1) | HU225158B1 (no) |
IL (2) | IL129298A0 (no) |
MY (1) | MY116980A (no) |
NO (1) | NO312960B1 (no) |
NZ (1) | NZ334971A (no) |
PL (1) | PL194673B1 (no) |
PT (1) | PT934280E (no) |
RU (1) | RU2180902C2 (no) |
SI (1) | SI0934280T1 (no) |
SK (1) | SK285878B6 (no) |
TR (1) | TR199900732T2 (no) |
UA (1) | UA62939C2 (no) |
WO (1) | WO1998014432A1 (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ298747B6 (cs) | 1998-04-01 | 2008-01-16 | Janssen Pharmaceutica N. V. | Derivát pyridinu, způsob jeho výroby a použití a farmaceutická kompozice s jeho obsahem |
US6953774B2 (en) | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
WO2002085855A1 (fr) * | 2001-04-19 | 2002-10-31 | Eisai Co., Ltd. | Derives de 2-iminopyrrolidine |
EP1389467B1 (en) | 2001-05-23 | 2013-07-03 | Mitsubishi Tanabe Pharma Corporation | Therapeutic composition for the regenerative treatment of cartilage diseases |
US20040220227A1 (en) * | 2001-07-11 | 2004-11-04 | Shinji Ina | Remedies for allergic eye diseases |
TWI221838B (en) | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
BRPI0117198B1 (pt) | 2001-12-14 | 2018-03-13 | Merck Serono S.A. | Usos de composição compreendendo um inibidor seletivo de uma isoforma 4 de fosfodiesterase |
EP2444393A1 (en) | 2003-02-19 | 2012-04-25 | Eisai R&D Management Co., Ltd. | Methods for producing cyclic benzamidine derivatives |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
US9957247B2 (en) * | 2012-06-07 | 2018-05-01 | Georgia State University Research Foundation, Inc. | SecA inhibitors and methods of making and using thereof |
GB2533925A (en) * | 2014-12-31 | 2016-07-13 | Univ Bath | Antimicrobial compounds, compositions and methods |
CN109438434B (zh) * | 2018-11-19 | 2021-05-04 | 华南农业大学 | 一种含噁唑环的2-氰基亚氨基噻唑烷类化合物及其制备方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0784461B2 (ja) * | 1986-12-19 | 1995-09-13 | 日本バイエルアグロケム株式会社 | 殺虫性ニトロイミノ又はシアノイミノ化合物 |
JPH05310650A (ja) * | 1991-08-22 | 1993-11-22 | Nippon Soda Co Ltd | 新規なアミン誘導体、その製造方法及び殺虫剤 |
NZ254881A (en) * | 1992-07-28 | 1996-09-25 | Rhone Poulenc Rorer Ltd | Diether, dithioether or diether thioether derivatives of 1,2-dihydroxybenzenes substituted in position-4 by an (hetero)aryl-containing group; |
PL309257A1 (en) * | 1992-12-02 | 1995-10-02 | Pfizer | Pirocatechin doethers as selective inhibitors of ped iv |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
JP3775685B2 (ja) * | 1993-07-28 | 2006-05-17 | ローン−プーラン・ロレ・リミテツド | Pde▲iv▼およびtnf抑制剤としての化合物 |
JPH09502170A (ja) * | 1993-08-19 | 1997-03-04 | スミスクライン・ビーチャム・コーポレイション | フェネチルアミン化合物 |
GB9401460D0 (en) * | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
MX9700068A (es) * | 1994-06-24 | 1997-12-31 | Euro Celtique Sa | Compuestos y metodo para inhibir a la fosfodiesterasa iv. |
TW424087B (en) * | 1995-04-06 | 2001-03-01 | Janssen Pharmaceutica Nv | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives |
TW375612B (en) * | 1995-04-06 | 1999-12-01 | Janssen Pharmaceutica Nv | 1,3-dihydro-2H-imidazol-2-one derivatives for the treatment of disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase type IV, preparation thereof and pharmaceutical composition containing the same |
TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
-
1997
- 1997-09-24 IL IL12929897A patent/IL129298A0/xx active IP Right Grant
- 1997-09-24 SI SI9730550T patent/SI0934280T1/xx unknown
- 1997-09-24 HU HU9904063A patent/HU225158B1/hu unknown
- 1997-09-24 CN CN97198460A patent/CN1106387C/zh not_active Expired - Lifetime
- 1997-09-24 DE DE69720757T patent/DE69720757T2/de not_active Expired - Lifetime
- 1997-09-24 NZ NZ334971A patent/NZ334971A/xx not_active IP Right Cessation
- 1997-09-24 PL PL97332573A patent/PL194673B1/pl unknown
- 1997-09-24 ES ES97910380T patent/ES2196308T3/es not_active Expired - Lifetime
- 1997-09-24 WO PCT/EP1997/005322 patent/WO1998014432A1/en active IP Right Grant
- 1997-09-24 AU AU47792/97A patent/AU719561B2/en not_active Expired
- 1997-09-24 AT AT97910380T patent/ATE236884T1/de active
- 1997-09-24 JP JP10516215A patent/JP3068208B2/ja not_active Expired - Lifetime
- 1997-09-24 SK SK344-99A patent/SK285878B6/sk not_active IP Right Cessation
- 1997-09-24 CA CA002267322A patent/CA2267322C/en not_active Expired - Lifetime
- 1997-09-24 PT PT97910380T patent/PT934280E/pt unknown
- 1997-09-24 DK DK97910380T patent/DK0934280T3/da active
- 1997-09-24 US US09/147,925 patent/US6051718A/en not_active Expired - Lifetime
- 1997-09-24 RU RU99109032/04A patent/RU2180902C2/ru active
- 1997-09-24 TR TR1999/00732T patent/TR199900732T2/xx unknown
- 1997-09-24 BR BRPI9712256-4A patent/BR9712256B1/pt not_active IP Right Cessation
- 1997-09-24 UA UA99031702A patent/UA62939C2/uk unknown
- 1997-09-24 EE EEP199900112A patent/EE03825B1/xx unknown
- 1997-09-24 CZ CZ0102899A patent/CZ297474B6/cs not_active IP Right Cessation
- 1997-09-24 KR KR10-1999-7001204A patent/KR100520002B1/ko not_active IP Right Cessation
- 1997-09-24 EP EP97910380A patent/EP0934280B1/en not_active Expired - Lifetime
- 1997-10-01 AR ARP970104528A patent/AR008875A1/es active IP Right Grant
- 1997-10-02 MY MYPI97004600A patent/MY116980A/en unknown
-
1999
- 1999-03-01 BG BG103220A patent/BG64278B1/bg unknown
- 1999-03-30 NO NO19991560A patent/NO312960B1/no not_active IP Right Cessation
- 1999-03-31 IL IL129298A patent/IL129298A/en not_active IP Right Cessation
- 1999-11-27 HK HK99105520A patent/HK1020344A1/xx not_active IP Right Cessation
-
2003
- 2003-11-04 CY CY0300074A patent/CY2380B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE215950T1 (de) | Carbolinderivate | |
DK0901474T3 (da) | Arylpyrimidinderivater | |
ATE261942T1 (de) | 6-phenylpyridinderivate | |
DK0934320T3 (da) | Naphthyridinderivater | |
DK1005446T3 (da) | N-aroylphenylalaninderivater | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
NO981946D0 (no) | Imidazoquinazolin-derivater | |
NO991560L (no) | PDE IV-inhiberende 2-cyanoiminoimidazol-derivater | |
DE69732576D1 (de) | Tetrahydrobenzindolon-derivate | |
ATE255098T1 (de) | Substituierte chromanderivate | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
ZA978809B (en) | PDE IV inhibiting 2-cyanoiminoimidazole derivatives | |
IS5026A (is) | 2-metoxýfenýlpíperasín afleiður | |
DK1068194T3 (da) | PDE IV-hæmmende pyridinderivater | |
ATE292632T1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
DK1015447T3 (da) | Piperidinylmethyloxazolidinonderivat | |
DE69710921D1 (de) | Heterocyclische substituierte pyrrolidinamid-derivate | |
ATA69896A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate | |
ATA73396A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |